More details on this developing story will follow.
Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript
By Dhallo News · September 1, 2026 at 2:04 AM IST
Original reporting: Seeking Alpha - Stock IdeasRead original report →
Have feedback on this article?Report error or suggestion
